21 Cfr 809 (2024)

1. CFR - Code of Federal Regulations Title 21 - FDA

§ 809.20 - General requirements for manufacturers and producers of in vitro diagnostic products. § 809.30 - Restrictions on the sale, distribution and use of ...
-

No information is available for this page. · Learn why
(a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that “a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper.”

[CITE: 21CFR809]. TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H - MEDICAL DEVICES. PART ...
See Also
Fruchtfliegen loswerden: 7 Mittel gegen Obstfliegen Wonton Air Fryer Recipes Unveiling the Grim Realities of Child Labor in Pakistan Unveiling Iqbal Masih's Legacy: A Beacon for Human Rights Vigilance
(a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that "a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper."

21 CFR Part 809 - PART 809—IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE · Subpart A—General Provisions (§§ 809.3 - 809.4) · Subpart B—Labeling (§§ 809.10 - 809.11) ...
21 U.S.C. 331, 351, 352, 355, 360b, 360c, 360d, 360h, 360i, 360j, 371, 372, 374, 381.

GMP Publications, Part 809 - In-Vitro Diagnostic Products.
See Also
Pinellas County Sheriff's Office Subject Charge Report
GMP Publications, Part 809 - In-Vitro Diagnostic Products

Sep 29, 2023 · We anticipate that applying the same oversight approach to laboratories and non-laboratories that manufacture IVDs would better assure the ...

(a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise ...
§ 809.10 Labeling for in vitro diagnostic products.

Oct 25, 2007 · 21 CFR Part 809, In Vitro Diagnostic Products for Human Use, found at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm ...

Introduction to Process Validation; Documentation & Audit Preparation; Mechanical Blueprint Reading; Welding Blueprint Reading; FDA Inspection ...
Awards & Memberships

Apr 29, 2024 · 21 CFR Part 809. [Docket No. FDA-2024-D-0083]. Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public Health. Response ...